- Home
- XNCR vs CCD Comparison
XNCR vs CCD Comparison
Compare XNCR & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CCD
- Stock Information
- Founded
- XNCR 1997
- CCD 2014
- Country
- XNCR United States
- CCD United States
- Employees
- XNCR N/A
- CCD N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CCD Trusts Except Educational Religious and Charitable
- Sector
- XNCR Health Care
- CCD Finance
- Exchange
- XNCR Nasdaq
- CCD Nasdaq
- Market Cap
- XNCR 579.3M
- CCD 592.8M
- IPO Year
- XNCR 2013
- CCD N/A
- Fundamental
- Price
- XNCR $9.65
- CCD $20.05
- Analyst Decision
- XNCR Buy
- CCD
- Analyst Count
- XNCR 8
- CCD 0
- Target Price
- XNCR $29.29
- CCD N/A
- AVG Volume (30 Days)
- XNCR 968.8K
- CCD 96.1K
- Earning Date
- XNCR 08-04-2025
- CCD 01-01-0001
- Dividend Yield
- XNCR N/A
- CCD 10.61%
- EPS Growth
- XNCR N/A
- CCD N/A
- EPS
- XNCR N/A
- CCD N/A
- Revenue
- XNCR $127,228,000.00
- CCD N/A
- Revenue This Year
- XNCR N/A
- CCD N/A
- Revenue Next Year
- XNCR $29.35
- CCD N/A
- P/E Ratio
- XNCR N/A
- CCD N/A
- Revenue Growth
- XNCR N/A
- CCD N/A
- 52 Week Low
- XNCR $7.16
- CCD $16.93
- 52 Week High
- XNCR $27.24
- CCD $24.68
- Technical
- Relative Strength Index (RSI)
- XNCR 59.62
- CCD 31.28
- Support Level
- XNCR $8.76
- CCD $20.00
- Resistance Level
- XNCR $9.60
- CCD $22.30
- Average True Range (ATR)
- XNCR 0.52
- CCD 0.38
- MACD
- XNCR 0.29
- CCD -0.13
- Stochastic Oscillator
- XNCR 90.87
- CCD 8.63
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.